Godwin Mary E. has filed 8 insider transactions across 1 company since February 2023.
Most recent transaction: a option exercise of 47031 shares of Nautilus Biotechnology, Inc. ($NAUT) on September 23, 2024.
Activity breakdown: 0 open-market purchases and 2 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sept. 23, 2024 | Nautilus Biotechnology, Inc. | $NAUT | Godwin Mary E. | Senior VP, Operations | M | Common Stock | 47031 | $0.46 | 47,031.0000 | 0 | 9999.99% | 0.00% |
| Sept. 23, 2024 | Nautilus Biotechnology, Inc. | $NAUT | Godwin Mary E. | Senior VP, Operations | S | Common Stock | 47031 | $2.87 | 0.0000 | 0 | 100.00% | 0.00% |
| Sept. 23, 2024 | Nautilus Biotechnology, Inc. | $NAUT | Godwin Mary E. | Senior VP, Operations | M | Stock Option (Right to Buy) | 47031 | $0.00 | 353,337.0000 | 0 | 11.75% | 0.00% |
| Sept. 17, 2024 | Nautilus Biotechnology, Inc. | $NAUT | Godwin Mary E. | Senior VP, Operations | M | Common Stock | 35000 | $0.46 | 35,000.0000 | 0 | 9999.99% | 0.00% |
| Sept. 17, 2024 | Nautilus Biotechnology, Inc. | $NAUT | Godwin Mary E. | Senior VP, Operations | S | Common Stock | 35000 | $2.85 | 0.0000 | 0 | 100.00% | 0.00% |
| Sept. 17, 2024 | Nautilus Biotechnology, Inc. | $NAUT | Godwin Mary E. | Senior VP, Operations | M | Stock Option (Right to Buy) | 35000 | $0.00 | 400,368.0000 | 0 | 8.04% | 0.00% |
| March 1, 2024 | Nautilus Biotechnology, Inc. | $NAUT | Godwin Mary E. | Senior VP, Operations | A | Stock Option (Right to Buy) | 160000 | $0.00 | 160,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 27, 2023 | Nautilus Biotechnology, Inc. | $NAUT | Godwin Mary E. | Senior VP, Operations | A | Stock Option (Right to Buy) | 160000 | $0.00 | 160,000.0000 | 0 | 9999.99% | 0.00% |